BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32842424)

  • 1. [Imaging modalities in the assessment of presacral recurrent rectal cancer].
    Wang Y; Yang S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):456-460. PubMed ID: 32842424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
    Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beware of False-Positive FDG PET/CT Interpretations for Presacral Recurrent Rectal Cancer.
    Pennings JP; de Haas RJ; de Jong KP; Dierckx RAJO; Kwee TC
    Clin Nucl Med; 2019 May; 44(5):e342-e344. PubMed ID: 30888991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidance of magnetic resonance imaging for target area delineation of postoperative presacral recurrence of rectal cancer].
    Li XN; Liu T; Wang C; Guo P; Ye YJ; Chen YL; Cheng J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Dec; 23(12):1170-1176. PubMed ID: 33353272
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer.
    Fukunaga H; Sekimoto M; Tatsumi M; Ikenaga M; Ohue M; Seshimo I; Higuchi I; Takayama O; Yasui M; Ikeda M; Yamamoto H; Monden M
    Int J Oncol; 2002 Apr; 20(4):691-5. PubMed ID: 11894111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
    Katsumoto Y; Maruyama N; Nakamura M; Shingai T; Maruyama K; Nakaguchi K; Furukawa J; Okajima S; Sue F; Fukunaga H; Ikenaga M; Sekimoto K
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1688-91. PubMed ID: 11708010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
    Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
    Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.
    Shao H; Ma X; Gao Y; Wang J; Wu J; Wang B; Li J; Tian J
    Medicine (Baltimore); 2018 Nov; 97(48):e12900. PubMed ID: 30508883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
    Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
    Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer.
    Bellomi M; Rizzo S; Travaini LL; Bazzi L; Trifirò G; Zampino MG; Radice D; Paganelli G
    Radiol Med; 2007 Aug; 112(5):681-90. PubMed ID: 17657420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
    Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C
    Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
    Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
    Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.
    Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U
    Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer.
    Chessin DB; Kiran RP; Akhurst T; Guillem JG
    J Am Coll Surg; 2005 Dec; 201(6):948-56. PubMed ID: 16310700
    [No Abstract]   [Full Text] [Related]  

  • 18. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
    Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
    Staib L; Schirrmeister H; Reske SN; Beger HG
    Am J Surg; 2000 Jul; 180(1):1-5. PubMed ID: 11036130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of
    Plodeck V; Platzek I; Streitzig J; Nebelung H; Blum S; Kühn JP; Hoffmann RT; Laniado M; Michler E; Hoberück S; Zöphel K; Kotzerke J; Fritzmann J; Weitz J; Radosa CG
    Abdom Radiol (NY); 2021 Nov; 46(11):5086-5094. PubMed ID: 34402948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.